Mass spectrometry methods for biomarker research for chronic lung allograft dysfunction (CLAD) in systems prediction of CLAD (SysCLAD)

J. Claustre, S. Quétant, C. Trocmé, S. Bourgoin-Voillard, H. Flamant-Waret, I. Bérard, B. Toussaint, K. Botturi-Cavaillès, A. Magnan, L. Nicod, C. Pison, M. Sève (Grenoble, Nantes, Lyon, France; Lausanne, Switzerland)

Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Session: Novel approaches in the management of lung transplant candidates and recipients
Session type: Thematic Poster Session
Number: 2457

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Claustre, S. Quétant, C. Trocmé, S. Bourgoin-Voillard, H. Flamant-Waret, I. Bérard, B. Toussaint, K. Botturi-Cavaillès, A. Magnan, L. Nicod, C. Pison, M. Sève (Grenoble, Nantes, Lyon, France; Lausanne, Switzerland). Mass spectrometry methods for biomarker research for chronic lung allograft dysfunction (CLAD) in systems prediction of CLAD (SysCLAD). Eur Respir J 2014; 44: Suppl. 58, 2457

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A new biomarker for chronic lung allograft dysfunction
Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Year: 2014

Risk factors for chronic lung allograft dysfunction (CLAD) in the SysCLAD cohort
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015

Orthotopic lung transplantation in a single-mismatch-based mouse model shows signs of chronic lung allograft dyfunction (CLAD)
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Regional specific gas volume as an early marker of chronic lung allograft dysfunction (CLAD)
Source: International Congress 2016 – Lung function and imaging: new findings and new approaches
Year: 2016

Cohort characteristics and chronic lung allograft dysfunction (CLAD) adjudication in a FP-7 funded project, Systems prediction of CLAD (SysCLAD)
Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Year: 2014

Blood mRNA and miRNA transcriptome to predict chronic lung allograft dysfunction
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015


Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD)
Source: International Congress 2018 – Rare lung diseases
Year: 2018


Oto score and medium-term outcomes in lung transplantation
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Breath VOC patterns of lung transplant recipients with and without chronic lung allograft dysfunction (CLAD)
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017

Prostacyclin and VEGF in the rejection process after lung transplantation – A possible biomarker
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

The impact of underlying disease on baseline pulmonary function values after lung transplantation
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016


Everolimus as a treatment of Chronic Lung Alograft Rejection (CLAD) in lung transplantation.
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019

A new lung donor scoring system
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014


Prediction of chronic lung allograft dysfunction: a systems medicine challenge
Source: Eur Respir J 2014; 43: 689-693
Year: 2014


Survival after redo-lung transplantion for CLAD according to phenotype - A multi-center study
Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Year: 2014


Predictive factors of restrictive allograft syndrome after lung-transplantation
Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Year: 2014

Discrimination of sepsis metabolic profiles revealed by LC/MS-MS based metabonomics approach
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013

Experience with application of ECMO in dubl lung transplantation
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014


NFkB location in T-cells is promising to monitor immunosuppression after lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014

A multi-omics data integration approach to identify a predictive molecular signature of CLAD
Source: International Congress 2015 – Predictors of lung transplant complications
Year: 2015